{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 455170527
| IUPAC_name = 1-({(2''R'',3''S'')-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1''H''-indol-2-yl}carbonyl)-<small>L</small>-prolinamide
| image = Relcovaptan.png
| width = 220

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_UK = <!-- GSL         / P       / POM / CD -->
| legal_US = <!-- OTC                   / Rx-only  -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| IUPHAR_ligand = 2200
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 150375-75-0
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 60943
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 419667
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = C1GL8G6G0O
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 54910

<!--Chemical data-->
| C=28 | H=27 | Cl=2 | N=3 | O=7 | S=1 
| molecular_weight = 620.501 g/mol
| smiles = COC1=C(C=C(C=C1)S(=O)(=O)N2[C@H]([C@](C3=C2C=CC(=C3)Cl)(C4=CC=CC=C4Cl)O)C(=O)N5CCC[C@H]5C(=O)N)OC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C28H27Cl2N3O7S/c1-39-23-12-10-17(15-24(23)40-2)41(37,38)33-21-11-9-16(29)14-19(21)28(36,18-6-3-4-7-20(18)30)25(33)27(35)32-13-5-8-22(32)26(31)34/h3-4,6-7,9-12,14-15,22,25,36H,5,8,13H2,1-2H3,(H2,31,34)/t22-,25-,28+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = CEBYCSRFKCEUSW-NAYZPBBASA-N
| synonyms = <small>(2''S'')-1-[(2''R'',3''S'')-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2''H''-indole-2-carbonyl]pyrrolidine-2-carboxamide</small>
}}

'''Relcovaptan''' ('''SR-49059''') is a non-[[peptide]] [[vasopressin receptor antagonist]], selective for the [[Arginine vasopressin receptor 1A|V1a]] subtype.<ref>Lemmens-Gruber R, Kamyar M. Vasopressin antagonists. ''Cellular and Molecular Life Sciences''. 2006 Aug;63(15):1766-79. {{PMID|16794787}}</ref> It has shown positive initial results in tests against [[Raynaud's disease]], [[dysmenorrhoea]], and [[tocolysis]],<ref>Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. ''Lancet''. 2008 May 10;371(9624):1624-32. {{PMID|18468546}}</ref> although it is not yet approved for clinical use.

==References==
{{Reflist|2}}


{{Oxytocin and vasopressin receptor modulators}}

[[Category:Hormonal agents]]
[[Category:Vasopressin receptor antagonists]]


{{systemic-hormonal-drug-stub}}